The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study evaluating efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy for patients with resectable rectal cancer (KSCC1301).
 
Kenji Katsumata
No Relationships to Disclose
 
Eiji Oki
Speakers' Bureau - Taiho Pharmaceutical; Yakult Honsha
 
Hiroyuki Kato
No Relationships to Disclose
 
Keisuke Miwa
No Relationships to Disclose
 
Masahiko Sugiyama
No Relationships to Disclose
 
Hidetsugu Murakami
No Relationships to Disclose
 
Hiroshi Hasegawa
No Relationships to Disclose
 
Shinichiro Mori
No Relationships to Disclose
 
Goro Nakayama
No Relationships to Disclose
 
Hiroshi Saeki
No Relationships to Disclose
 
Mototsugu Shimokawa
No Relationships to Disclose
 
Yoshihiro Kakeji
Speakers' Bureau - Taiho Pharmaceutical; Yakult Honsha
 
Hideo Baba
Speakers' Bureau - Taiho Pharmaceutical; Yakult Honsha
Research Funding - Taiho Pharmaceutical
 
Yoshito Akagi
Speakers' Bureau - Taiho Pharmaceutical
 
Yoshihiko Maehara
Speakers' Bureau - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical; Yakult Honsha